Skip to Main Content

Advertisement

Skip Nav Destination

Abstract 952: The bispecific antibody MCLA-129 impairs NSCLC tumor growth by targeting EGFR and c-MET, inhibiting ligand-induced signaling and promoting ADCC and ADCP

Cancer Res (2021) 81 (13_Supplement): 952.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
  • Wanying Wang
  • Tianyu Qiu
  • Fei Li
  • Shengxiang Ren
Chinese Medical Journal (2023) 136 (4): 379.
  • Joanna Pastwińska
  • Kaja Karaś
  • Iwona Karwaciak
  • Marcin Ratajewski
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2022) 1877 (4): 188754.
  • Fedor Moiseenko
  • Alexey Bogdanov
  • Vitaliy Egorenkov
  • Nikita Volkov
  • Vladimir Moiseyenko
Current Treatment Options in Oncology (2022) 23 (12): 1664.
Close Modal

or Create an Account

Close Modal
Close Modal